MIRDETECT
miRdetect, is a startup that develops a test method for the detection of testicular cancer
MIRDETECT
Industry:
Biotechnology Health Care Software
Founded:
2016-01-01
Address:
Bremen, Bremen, Germany
Country:
Germany
Website Url:
http://www.mirdetect.de
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Font Awesome Apache Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
2Bridge
2 Bridge is a virtual team that helps to advance healthcare product development by providing pharmaceutical R&D.
ARCEDI Biotech
ARCEDI Biotech is a biotech company, develops technologies and methods for detecting and diagnosing rare cancer cells.
Decodon Gmbh
DECODON GmbH is a bioinformatics company that develops innovative software for the modern Life Sciences.
Current Employees Featured
Founder
Investors List
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Seed Round - miRdetect
BAB Beteiligungs- und Managementgesellschaft Bremen
BAB Beteiligungs- und Managementgesellschaft Bremen investment in Seed Round - miRdetect
Official Site Inspections
http://www.mirdetect.de
- Host name: 217-160-0-13.elastic-ssl.ui-r.com
- IP address: 217.160.0.13
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "miRdetect"
mir | detect - Start
Wir entwickeln, produzieren und vertreiben hoch sensitive und zuverlässige molekularbiologische Tests zur Früherkennung und Diagnose von Krebserkrankungen. Eine Blutprobe genügt. Die von mir|detect entwickelten …See details»
Start - mir | detect
We develop, produce, and distribute highly sensitive and reliable molecular tests for the early detection and diagnosis of cancer. One blood sample is sufficient. The method developed by mir|detect detects minute amounts of nucleic acids …See details»
mir | detect - Company
Mir|detect creates reliability and certainty not only in the section of testicular cancer. mir|detect: Biotechnology from Bremerhaven. Successful CE 2797 certification of the M371-Test …See details»
miRdetect - Crunchbase Company Profile & Funding
MiRdetect develops a test method for the detection of testicular cancer. miRdetect creates, manufactures, and markets molecular biological tests for cancer early detection and diagnosis. …See details»
miRdetect GmbH Company Profile | Bremerhaven, Bremen, …
Find company research, competitor information, contact details & financial data for miRdetect GmbH of Bremerhaven, Bremen. Get the latest business insights from Dun & Bradstreet.See details»
mir|detect - LinkedIn
Mir|detect | 217 followers on LinkedIn. we create innovative in vitro diagnostic kits | mir|detect GmbH develops, produces and sells innovative test-kits for in vitro diagnostics.See details»
MiRdetect (miRdetect GmbH) - Startbase
MiRdetect GmbH is a biotechnology company founded with the vision to revolutionize cancer diagnostics. The focus is on the development, production and distribution of in-vitro diagnostics based on molecular diagnostic methods.See details»
Meike Spiekermann (miRdetect GmbH) - Life-Sciences-Europe.com
With the test kit developed by miRdetect, testicular cancer can be diagnosed with high specificity in the patient’s blood using a patented molecular diagnostic procedure. In addition, this …See details»
detect - Info Portal - mir
Testicular tumors develop mostly through faulty ripening of primordial germ cells, which are produced in the testicles. The result is uninhibited cell division and production which can lead …See details»
mir|detect Company Profile 2024: Valuation, Funding
Developer of a diagnostic testing technology designed to detect testicular cancer. The company's technology helps to develop, produce, and sell sensitive and reliable molecular biological tests for the early detection and diagnosis of …See details»
miRdetect GmbH: Informationen und Neuigkeiten - XING
Mir|detect develops, produces, and distributes highly sensitive and reliable molecular tests for cancer diagnostics The method developed by mir|detect detects minute amounts of nucleic …See details»
miRdetect - Products, Competitors, Financials, Employees, …
MiRdetect focuses on developing, producing, and distributing highly sensitive and reliable molecular biology tests for the early detection and diagnosis of cancer. Use the CB Insights …See details»
miRdetect GmbH - Bremen, Germany - bionity.com
MiRdetect has developed an innovative test procedure that enables the early and exact detection of cancer. This is applicable to genetic material of any origin and has the potential for highly …See details»
miRdetect GmbH - VentureRadar
MiRdetect has developed a technology with which it is possible to quantitatively determine every type of nucleic acid in body fluids at the lower... ... Find out more about miRdetect GmbH, …See details»
miRdetect Company Profile - Office Locations, Competitors, …
MiRdetect is a company engaged in the development of in-vitro diagnostics. It develops a test method for the detection of testicular cancer. In addition, the Company provides a miRcontrol …See details»
mir | detect - Unternehmen
Der von mir|detect entwickelte M371-Test zum Nachweis und Monitoring von testikulären Keimzelltumoren besitzt seit April 2024 die Zulassung gemäß Verordnung 2017/746 IVDR und …See details»
Start-up miRdetect receives seed financing - Consortium invests …
May 3, 2019 · Together with BBM and a private investor, High-Tech Gründerfonds (HTGF) is investing a seven-figure sum in the start-up company miRdetect located in Bremen, and …See details»
miRdetect - Company Profile - Tracxn
Nov 17, 2024 · miRdetect - Provider of test kit for the detection of serum tumor. Raised funding over 2 rounds from 3 investors. Founded by Gazanfer Belge and Klaus Dieckmann in the year …See details»
TECHNOLOGIE - mir | detect
Die von mir|detect entwickelte Methode bietet einen wesentlichen Schritt hin zu mehr Lebensqualität für Ihre Patienten. Unser Liquid Biopsy Verfahren hat das Potenzial, den …See details»
Produkte - mir | detect
Das von mir|detect entwickelte Diagnose-Verfahren, die Basis des M371-Tests, löst dieses offenkundige Problem, da so CT Untersuchungen weiter minimiert oder auch ganz abgeschafft …See details»